Roche Buys Innovatis for $20.5M in Bid to Boost Bioproduction, Cell Fermentation QC Play

Innovatis' cell counting, cell viability testing, and cell acquisition measurement technology is compatible with Roche's xCELLigence platform, according to a Roche Applied Science official.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.